Ipsen (XPAR:IPNNV) Days Payable : 459.73 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Ipsen Days Payable?

Ipsen's average Accounts Payable for the six months ended in Dec. 2023 was €759 Mil. Ipsen's Cost of Goods Sold for the six months ended in Dec. 2023 was €301 Mil. Hence, Ipsen's Days Payable for the six months ended in Dec. 2023 was 459.73.

The historical rank and industry rank for Ipsen's Days Payable or its related term are showing as below:

XPAR:IPNNV' s Days Payable Range Over the Past 10 Years
Min: 196.98 Med: 306.51 Max: 461.17
Current: 461.17

During the past 13 years, Ipsen's highest Days Payable was 461.17. The lowest was 196.98. And the median was 306.51.

XPAR:IPNNV's Days Payable is ranked better than
92.83% of 976 companies
in the Drug Manufacturers industry
Industry Median: 86.915 vs XPAR:IPNNV: 461.17

Ipsen's Days Payable increased from Dec. 2022 (391.36) to Dec. 2023 (459.73). It may suggest that Ipsen delayed paying its suppliers.

Ipsen Days Payable Historical Data

The historical data trend for Ipsen's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Days Payable Chart

Ipsen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

332.20

373.37

453.50

429.46

453.21

Ipsen Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															432.11	441.93	391.36	471.19	459.73

Competitive Comparison of Ipsen's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipsen's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's Days Payable distribution charts can be found below:

* The bar in red indicates where Ipsen's Days Payable falls into.

Ipsen Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ipsen's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (647.1	+	771.4)	/	2 )	/	571.2	*	365
=	709.25					/	571.2	*	365
=	453.21

Ipsen's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (746.6	+	771.4)	/	2 )	/	301.3	*	365 / 2
=	759					/	301.3	*	365 / 2
=	459.73

Ipsen Days Payable Related Terms

Thank you for viewing the detailed overview of Ipsen's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen (XPAR:IPNNV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (XPAR:IPNNV) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPSEF:USA 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen (XPAR:IPNNV) Headlines

No Headlines